ASCO 2026 Session: Celebrating 10 Years of NCI's Affordable Cancer Technologies (ACTs) Program

Learn more

Since its launch in 2014, the Affordable Cancer Technologies (ACTs) program has supported 38 research project grants and grown into a robust portfolio of technology-driven research aimed at making high-quality cancer services more accessible globally. This anniversary is marked by a Special Series in JCO Global Oncology dedicated to the work of ACTs-supported investigators and the partnerships that have shaped a new generation of cancer technologies. 

Join us for a special presentation by JCO Global Oncology co-editors Paul C. Pearlman, PhD, and Fabio Ynoe de Moraes, MD, PhD, MBA. The session will spotlight their recently published special series, "10 Years of the National Cancer Institute's Affordable Cancer Technologies Program." This event is a part of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.